Analyst firms · Barclays · EXPE
Barclays EXPE price target and rating history
Expedia Group Inc. (EXPE) · Consumer Discretionary
Barclays rates Expedia Group Inc. (EXPE) Equal Weight with a $150 price target, as of its latest action on Dec 12, 2023. It has published 5 rating actions on EXPE since August 2021, including 0 upgrades and 1 downgrade. Across 4 firms with a EXPE price target in the last 12 months, the median target is $317.
- Current rating
- Equal Weight
- Price target
- $150
- Median target, all firms
- $317
- Actions on EXPE
- 5
Barclays price target on EXPE
Every Barclays rating on EXPE
- Dec 12, 2023
- Oct 9, 2023
- Feb 11, 2022
- Nov 5, 2021
- Aug 6, 2021
How other firms rate EXPE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Morgan Stanley | Underweight | $235 | Sep 16, 2026 |
| Rosenblatt | Neutral | $360 | Sep 1, 2026 |
| Wedbush | Outperform | $334 | Jul 16, 2026 |
| Jefferies | Buy | $300 | Mar 30, 2026 |
| BNP Paribas Exane | Neutral | Nov 24, 2025 |
Questions about Barclays and EXPE
- What is Barclays's price target for EXPE?
- Barclays's latest stated price target for Expedia Group Inc. (EXPE) is $150, from its action on Dec 12, 2023.
- What is Barclays's rating on EXPE?
- Barclays rates EXPE Equal Weight, a neutral rating, as of Dec 12, 2023.
- When did Barclays last change its view on EXPE?
- On Dec 12, 2023, Barclays downgrades to Equal Weight from Overweight, price target $136 to $150.
- How does Barclays's EXPE target compare with other analysts?
- Across 4 firms with a EXPE price target in the last 12 months, the median target is $317.
More EXPE rating histories
- Morgan Stanley4
- Piper Sandler5
- BofA Securities4
- TD Cowen3
- Truist Securities3
- BTIG3
- Gordon Haskett3
- Stifel3
- RBC Capital Markets3
All Barclays ratingsEXPE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.